Literature DB >> 2148181

Characterization of the product of the gtfS gene of Streptococcus downei, a primer-independent enzyme synthesizing oligo-isomaltosaccharides.

R R Russell1, M L Gilpin, N Hanada, Y Yamashita, Y Shibata, T Takehara.   

Abstract

The gtfS gene, coding for a glucosyltransferase which synthesizes water-soluble glucan and previously cloned from Streptococcus downei strain MFe28 (mutans serotype h) into a bacteriophage vector, was subcloned into a plasmid vector. The gtfS gene products expressed in Escherichia coli were compared to the primer-independent, oligo-isomaltosaccharide synthase in Streptococcus sobrinus strain AHT (mutans serotype g) and shown to resemble it closely in molecular mass, isoelectric point, immunological properties, optimum pH and Km values. The glucans produced from sucrose by the gtfS gene products are alpha-1,6-linked linear oligo-isomaltosaccharides without any branching sites. A similar gtfS gene was also detected on chromosomal DNA from S. sobrinus strain AHT.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2148181     DOI: 10.1099/00221287-136-8-1631

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  4 in total

1.  Antigenicity of a synthetic peptide from glucosyltransferases of Streptococcus mutans in humans.

Authors:  J S Chia; S W Lin; C S Yang; J Y Chen
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

2.  Expression of gtfS is essential for normal insoluble glucan synthesis by Streptococcus downei.

Authors:  K S Gilmore; R R Russell; J J Ferretti
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

3.  Nucleotide sequence analysis of the gtfT gene from Streptococcus sobrinus OMZ176.

Authors:  N Hanada; Y Isobe; Y Aizawa; T Katayama; S Sato; M Inoue
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

4.  Cloning of a Streptococcus sobrinus gtf gene that encodes a glucosyltransferase which produces a high-molecular-weight water-soluble glucan.

Authors:  N Hanada; Y Yamashita; Y Shibata; S Sato; T Katayama; T Takehara; M Inoue
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.